The Cooper Companies, Inc. COO

Healthcare · Medical Instruments & Supplies · valued as of 2026-11-03 · statements 2025-10-31

Average Intrinsic Value
$4.28B
Market Cap
$10.93B
Margin of Safety
-155.6%
Intrinsic / Market Ratio
0.39

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

3.47B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

4.87B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

4.50B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

4.28B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

4.28B USD

from the sum above

Market Cap

10.93B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.39×

the ratio the screener ranks by; Margin of Safety -155.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 3.47B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)5.86B USD
−②Net Debt Today2.39B USD
+③Growth Value0 USD
=Value3.47B USD

EPV of the Operations (NOPAT over WACC)

5.86B USD

Net debt today

-2.39B USD

Growth Value

0 USD

Value

3.47B USD

①EPV (earnings power value)

5.86B USD

②Net Debt Today

2.39B USD

③Growth Value

0 USD

Market value

Market Cap10.93B USD

Today's price times the shares.

Value vs market

Margin of Safety-215.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 4.87B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.99B USD
+②Equity at Year 15, Today2.87B USD
=Value4.87B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.99B USD

②Equity at Year 15, Today

2.87B USD

Market value

Market Cap10.93B USD

Today's price times the shares.

Value vs market

Margin of Safety-124.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 4.50B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF2.55B USD
+②Invested Capital at Year 15, Today4.34B USD
−③Net Debt Today2.39B USD
=Value4.50B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

2.55B USD

②Invested Capital at Year 15, Today

4.34B USD

③Net Debt Today

2.39B USD

Market value

Market Cap10.93B USD

Today's price times the shares.

Value vs market

Margin of Safety-143.1%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 8.12%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.82×Market Risk Premium 6.00%= 9.41%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 191.79M USDPretax Income 567.07M USD= 33.82%

The tax the interest saves.

Interest Expense =EBIT 667.17M USD−Pretax Income 567.07M USD= 100.10M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 100.10M USDTotal Debt 2.55B USD×(1 − Tax Rate for WACC 33.82%)= 2.60%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 2.55B USDMarket Cap + Total Debt 10.93B USD + 2.55B USD= 18.90%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 81.10%×Cost of Equity 9.41%+Debt Weight 18.90%×Cost of Debt 2.60%= 8.12%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-07-31.

Total Assets 12.69B USD − Total Liabilities 4.35B USD = Book Value Today 8.34B USD

Total Debt 2.55B USD − Cash and Short-Term Investments 154.85M USD = Net Debt Today 2.39B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-4.0%at most 5%passes190,100,000 / 198,096,596
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets3.3%at least -10.0%passes(796.90M USD − 375.27M USD) ÷ 12.69B USD
Price to bookMarket Cap ÷ Book Value Today1.31×at most 3×passes10.93B USD ÷ 8.34B USD
Operating marginOperating Income ÷ Revenue16.7%above 10.0%passes683.58M USD ÷ 4.10B USD
Revenue growthRevenue ÷ Revenue a Year Before − 15.1%above 10.0%does not pass4.10B USD / 3.90B USD
Net cash(Cash − Total Debt) ÷ Market Cap-21.9%above -30%passes(154.85M USD − 2.55B USD) ÷ 10.93B USD
Operating efficiencyOperating Income ÷ Gross Profit25.5%above 25.0%passes683.58M USD ÷ 2.68B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

57 USD

Enterprise value

13.58B USD

market cap plus net debt

EV / EBITDA

14.55×

Price / book

1.31×

the provider's book

Price / earnings

19.73×

Return on equity

6.8%

the provider's, not the engine's

Profit margin

13.5%

Revenue growth

0.6%

Analyst target, mean

66 USD

Analysts

14

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

3.31B3.60B3.90B4.10B

Gross profit

2.14B2.36B2.60B2.68B

Operating income

508.11M533.63M706.41M683.58M

EBITDA

operating income before depreciation and amortisation

879.58M886.79M1.07B1.04B

Pretax income

475.78M413.31M582.88M567.07M

Net income

386.19M294.49M392.69M375.27M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

386.19M294.49M396.20M380.58M

R&D

110.41M137.54M155.26M172.37M
Balance sheet, year end

Total assets

11.50B11.67B12.33B12.41B

Total liabilities

4.32B4.11B4.24B4.16B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

7.18B7.56B8.09B8.25B

Total debt

2.77B2.57B2.59B2.51B

Cash and equivalents

138.34M120.92M107.71M110.71M

Net PP&E

fixed assets after depreciation

1.43B1.63B1.87B2.08B

Working capital

current assets less current liabilities

253.65M736.64M929.63M994.59M
Cash flow

Operating cash flow

693.09M608.11M710.01M796.90M

Capital expenditure

paid out, so below zero

-242.24M-392.89M-421.62M-362.76M

Depreciation and amortisation

346.45M368.07M375.48M377.78M

Free cash flow

operating cash flow plus capital expenditure

450.85M215.21M288.39M434.13M